Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products 2021-11-25 00:18
iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA 2019-12-11 22:00
First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA 2019-05-21 18:11
1